Senseonics, Beta Bionics launch integrated glucose monitoring and insulin delivery system
SENS•Senseonics and Beta Bionics launched the Eversense 365 glucose monitoring system integrated with the iLet Bionic Pancreas, meeting their fourth-quarter 2026 target. The system combines a one-year glucose sensor with automated insulin dosing.
1. System launch
Senseonics and Beta Bionics launched the Eversense 365 glucose monitoring system integrated with the iLet Bionic Pancreas. The launch meets the fourth-quarter 2026 target set under their partnership announced in September 2026.
2. Planned integration
The companies also plan to integrate Eversense 365 with Beta Bionics' Mint tubeless patch pump.




